Rocio Benito

Salamanca, CL, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Corrigendum to 'A Novel Homozygous Splice-Site Variant in VPS33B Identified as a Cause of Bleeding': [JTHA 24/1, January 2026, Pages 146-154].

Corrigendum to 'A Novel Homozygous Splice-Site Variant in VPS33B Identified as a Cause of Bleeding': [JTHA 24/1, January 2026, Pages 146-154].

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 10, 2026

A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding: reply to the letter to the editor.

A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding: reply to the letter to the editor.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 15, 2026

Efficacy and safety of recombinant activated factor VII for secondary prophylaxis in patients with Glanzmann thrombasthenia.

Efficacy and safety of recombinant activated factor VII for secondary prophylaxis in patients with Glanzmann thrombasthenia.

Journal: Research and practice in thrombosis and haemostasis

Published: April 07, 2026

Comprehensive genetic characterization of adult BCR::ABL1-negative B-ALL by Optical Genome Mapping and Targeted NGS.

Comprehensive genetic characterization of adult BCR::ABL1-negative B-ALL by Optical Genome Mapping and Targeted NGS.

Journal: Blood advances

Published: February 10, 2026

ZMYM3 mutations modulate histone acetylation and cooperate with NOTCH1 mutations in chronic lymphocytic leukemia.

ZMYM3 mutations modulate histone acetylation and cooperate with NOTCH1 mutations in chronic lymphocytic leukemia.

Journal: Blood advances

Published: December 24, 2025

Optimizing Surgical Approaches for Patients with Inherited Factor VII Deficiency.

Optimizing Surgical Approaches for Patients with Inherited Factor VII Deficiency.

Journal: Thrombosis and haemostasis

Published: December 24, 2025

Characterization of Novel Variants in P2YRY12, GP6 and TBXAS1 in Patients with Lifelong History of Bleeding.

Characterization of Novel Variants in P2YRY12, GP6 and TBXAS1 in Patients with Lifelong History of Bleeding.

Journal: Biomolecules

Published: October 22, 2025

Improvement in health‑related quality of life in patients with heavy menstrual bleeding after treatment and its association with hereditary bleeding disorders.

Improvement in health‑related quality of life in patients with heavy menstrual bleeding after treatment and its association with hereditary bleeding disorders.

Journal: BMC women's health

Published: September 12, 2025

A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding.

A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 25, 2025

Examining the Effects of the RUNX1 p.Leu43Ser Variant on FPD/AML Phenotypes Using a CRISPR/Cas9-Generated Knock-In Murine Model.

Examining the Effects of the RUNX1 p.Leu43Ser Variant on FPD/AML Phenotypes Using a CRISPR/Cas9-Generated Knock-In Murine Model.

Journal: Biomolecules

Published: April 03, 2025

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk.

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk.

Journal: British journal of haematology

Published: March 08, 2025

ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

Journal: Leukemia

Published: December 20, 2024

Showing 1-12 of 76

Last Updated: 09/26/2026